Colin Baigent
0000-0003-4856-7420
Publication & Citation Trends
Publications
0 total
Estimated glomerular filtration rate, albuminuria, and risk of infection: a collaborative meta-analysis of individual participant data
Cited by 0
Semantic Scholar
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY.
Cited by 2
Semantic Scholar
Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.
Cited by 1
Semantic Scholar
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial
Cited by 4
Semantic Scholar
2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations I: therapy and prevention. OA
Cited by 13
Semantic Scholar
Chronic kidney disease and incident cancer risk: an individual participant data meta-analysis
Cited by 2
Semantic Scholar
Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: an individual participant-level meta-analysis.
Cited by 3
Semantic Scholar
Research Topics
Lipoproteins and Cardiovascular Health
(72)
Antiplatelet Therapy and Cardiovascular Diseases
(52)
Chronic Kidney Disease and Diabetes
(44)
Health Systems, Economic Evaluations, Quality of Life
(38)
Blood Pressure and Hypertension Studies
(35)
Affiliations
University of Bergamo
National Academy of Medicine
Merck & Co., Inc., Rahway, NJ, USA (United States)
Tri-Service General Hospital
National Institutes of Health